Revolution Medicines Ownership | Who Owns Revolution Medicines?
Revolution Medicines Ownership Summary
Revolution Medicines is owned by 16.01% institutional investors, 1.87% insiders, and 82.12% retail investors. Vanguard group is the largest institutional shareholder, holding 8.32% of RVMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Revolution Medicines shares.
RVMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Revolution Medicines | 16.01% | 1.87% | 82.12% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 15.66M | 8.32% | $731.47M |
| Farallon capital management | 14.63M | 7.77% | $683.02M |
| Janus henderson group | 9.48M | 5.68% | $414.78M |
| Wellington management group llp | 9.81M | 5.22% | $458.29M |
| Baker bros. advisors lp | 9.46M | 5.03% | $441.57M |
| Fmr | 9.40M | 5.00% | $439.06M |
| Nextech invest | 7.60M | 4.56% | $332.47M |
| Blackrock funding, inc. /de | 8.33M | 4.43% | $388.91M |
| Nextech invest | 7.60M | 4.04% | $354.97M |
| Paradigm biocapital advisors lp | 6.22M | 3.31% | $290.63M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mass general brigham | 338.19K | 63.90% | $13.13M |
| Nextech invest | 7.60M | 54.03% | $354.97M |
| Nextech invest | 7.60M | 53.94% | $332.47M |
| Lunate rsc | 2.20M | 45.54% | $96.06M |
| Casdin capital | 2.65M | 10.31% | $123.63M |
| Ah capital management | 2.75M | 9.20% | $128.36M |
| Boxer capital | 4.28M | 8.75% | $166.09M |
| Lunate capital | 2.20M | 8.56% | $102.56M |
| Paradigm biocapital advisors lp | 6.22M | 8.27% | $290.63M |
| Alphabet | 4.13M | 8.01% | $193.02M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 9.48M | 0.21% | 3.35M |
| General atlantic | 2.47M | 3.47% | 2.47M |
| Lunate rsc | 2.20M | 45.54% | 2.20M |
| Norges bank | 1.74M | 0.01% | 1.74M |
| Nextech invest | 7.60M | 53.94% | 1.30M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 738.03K | 0.00% | -1.42M |
| Balyasny asset management | - | - | -1.30M |
| Bvf inc/il | 3.97M | 7.52% | -1.01M |
| Price t rowe associates inc /md/ | 3.87M | 0.02% | -828.26K |
| Qube research | - | - | -786.02K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| General atlantic | 2.47M | 3.47% | 2.47M | $115.56M |
| Lunate rsc | 2.20M | 45.54% | 2.20M | $96.06M |
| Norges bank | 1.74M | 0.01% | 1.74M | $76.20M |
| Tcg crossover management | 436.47K | 1.00% | 436.47K | $20.38M |
| Pfm health sciences, lp | 331.07K | 1.19% | 331.07K | $15.46M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| American capital advisory | -6.00 |
| Principal securities | -8.00 |
| Wolff wiese magana | -9.00 |
| Bokf, na | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 114 | -63.34% | 30,120,079 | -83.73% | 16 | 0.17% | 59 | -64.88% | 31 | -63.95% |
| Jun 30, 2025 | 318 | 8.53% | 190,637,976 | -0.22% | 101 | 0.98% | 170 | 18.06% | 89 | - |
| Mar 31, 2025 | 25 | -91.50% | 35,140,611 | -81.80% | 18 | 0.14% | 15 | -92.11% | 6 | -89.09% |
| Dec 31, 2024 | 277 | 5.73% | 184,740,316 | 9.37% | 110 | 1.08% | 179 | 20.95% | 52 | -16.13% |
| Sep 30, 2024 | 260 | 14.54% | 168,886,065 | 0.30% | 101 | 973278.73% | 148 | 18.40% | 62 | 8.77% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.28M | 2.82% | -110.56K |
| Vanguard US Total Market Shares ETF | 4.74M | 2.55% | 4.24K |
| BB Biotech AG Ord | 4.37M | 2.37% | -484.46K |
| iShares Russell 2000 ETF | 4.27M | 2.29% | - |
| Vanguard Small Cap Index | 4.07M | 2.18% | -22.59K |
| Vanguard Health Care Inv | 3.87M | 2.08% | -946.03K |
| Fidelity Growth Compy Commingled Pl S | 3.27M | 1.75% | 207.40K |
| Janus Inst Mid Cap Growth CF | 2.40M | 1.29% | 377.18K |
| Janus Henderson Enterprise D | 2.40M | 1.29% | - |
| Fidelity Growth Company Fund | 2.40M | 1.28% | 142.40K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 25, 2025 | Anders Jack | Chief Financial Officer | Sell | $400.93K |
| Nov 25, 2025 | GOLDSMITH MARK A | See Remarks | Sell | $4.50M |
| Nov 25, 2025 | GOLDSMITH MARK A | See Remarks | Sell | $225.00K |
| Nov 18, 2025 | GOLDSMITH MARK A | See Remarks | Sell | $1.41M |
| Nov 18, 2025 | Cislini Jeff | General Counsel | Sell | $939.01K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 9 |
| 2025 Q3 | - | 13 |
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 7 |
| 2024 Q4 | 2 | 23 |
RVMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools